US company withdraws ALS drug after it fails in trial
Washington (AFP) - Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after ...
Washington (AFP) - Amylyx Pharmaceuticals announced Thursday it was withdrawing its approved treatment against the deadly neurodegenerative disease ALS after ...
Washington (AFP) - A new treatment shows promise against the deadly neurodegenerative disease ALS, a study based on mice showed ...
© 2023 - Premium news by MagnifyPost.